Keyphrases
Transplantation
100%
Cytomegalovirus
100%
Epstein-Barr Virus
100%
Virus Transmission
100%
Kidney Donor
100%
Valganciclovir
100%
Placebo
20%
Virus Replication
20%
Pretransplant
20%
Post-transplant Lymphoproliferative Disorder
20%
Viremia
20%
Placebo Groups
20%
Virus Diseases
20%
Antiviral Prophylaxis
20%
Donor Pretreatment
20%
Prospective Randomized Trial
10%
Donor Organs
10%
Virus
10%
Transplant Recipients
10%
Placebo-controlled Trial
10%
Cytomegalovirus Disease
10%
Lymphoid Tissue
10%
Donor-recipient Matching
10%
Oral Rinse
10%
Latent Membrane Protein 1 (LMP1)
10%
Tissue Biopsy
10%
Epstein-Barr Virus Infections
10%
Between-group
10%
Viral Disease
10%
Survival Time
10%
Sequence Variation
10%
Survival Duration
10%
Leukopenia
10%
Virus Strains
10%
Donor Source
10%
Free Survival
10%
NO Donors
10%
Plasma Epstein-Barr Virus DNA
10%
Cytomegalovirus Replication
10%
Medicine and Dentistry
Cytomegalovirus
100%
Virus Transmission
100%
Epstein Barr Virus
100%
Valganciclovir
100%
Placebo
50%
Virus Infection
30%
Virus Replication
20%
Viremia
20%
Posttransplant Lymphoproliferative Disease
20%
Side Effect
10%
Leukopenia
10%
Cytomegalovirus Infection
10%
Virus Strain
10%
Organ Donor
10%
Survival Time
10%
Virus DNA
10%
Biopsy Technique
10%
Latent Membrane Protein 1
10%
Epstein-Barr Virus Infection
10%
Virus
10%
Lymphatic Tissue
10%
Diseases
10%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Cytomegalovirus
100%
Virus Transmission
100%
Valganciclovir
100%
Placebo
50%
Virus Infection
30%
Viremia
20%
Posttransplant Lymphoproliferative Disease
20%
Side Effect
10%
Cytomegalovirus Infection
10%
Virus DNA
10%
Epstein Barr Virus Infection
10%
Survival Time
10%
Epstein-Barr Virus Latent Membrane Protein 1
10%
Virus Strain
10%
Leukopenia
10%
Diseases
10%
Immunology and Microbiology
Virus Transmission
100%
Cytomegalovirus
100%
Epstein Barr Virus
100%
Viral Replication
20%
Lymphoproliferative Disorders
20%
Viral Disease
20%
Viremia
20%
Lymphoid Tissue
10%
Virus
10%
Survival Time
10%
Virus Strain
10%
Epstein-Barr Virus Latent Membrane Protein 1
10%
DNA Virus
10%